Atherosclerosis and Lipoproteins |
From the Departments of Biochemistry (M.S.K., M.C.d.B., J.Y.), Surgery (M.S.K., J.Y.), and Internal Medicine (M.S.K., M.C.d.B., F.C.d.B.) and the Stroke Program of the Sanders-Brown Center on Aging (M.S.K., J.Y.), University of Kentucky School of Medicine, Lexington, and the Department of Veterans Affairs Medical Center (M.S.K., M.C.d.B., F.C.d.B.), Lexington, Ky.
Correspondence to Mark S. Kindy, PhD, Department of Biochemistry, University of Kentucky Medical Center, 800 Rose St, Lexington, KY 40536-0084. E-mail mskindy{at}pop.uky.edu
AbstractThe serum amyloid A
(SAA) family of proteins consists of inducible acute-phase members and
a constitutive member that are minor apolipoproteins of normal high
density lipoprotein (HDL). During inflammation, HDL
cholesterol and apolipoprotein A-I (apoA-I) protein are
decreased, and these changes are thought to be partly related to the
increase in acute-phase SAA proteins that associate with the HDL
particle to become the major apolipoprotein species. To determine the
specific role of SAA in the alteration of HDL in the absence of a
generalized acute-phase response, acute-phase Saa1.1
transgene expression was directed via an inducible mouse
metallothionein promoter. Elevated levels of SAA1.1
(28±9 mg/dL) comparable to a moderate acute-phase response were
achieved over a 5-day period. SAA association with the HDL particles at
this concentration did not significantly alter the apoA-I or HDL
cholesterol levels or change the lipoprotein profiles in
the transgenic mice compared with wild-type mice. In addition, we used
adenoviral vectors to increase the SAA expression to levels seen in a
major acute-phase response. Injection of adenovirus expressing the
mouse SAA1.1 protein resulted in high-level expression (72±8 mg/dL)
but did not alter apoA-I levels. However, the SAA associated with the
HDL particle gave rise to significantly larger HDL particles (
10%).
Adenoviral expression of the constitutive SAA4 protein resulted in an
increase in HDL size (
10%) and an increase in very low density
lipoprotein levels (20-fold) and triglyceride levels
(1.7-fold). These studies suggest that increases in acute-phase SAA
proteins alone are insufficient to alter HDL cholesterol or
apoA-I levels during inflammation. A role for constitutive SAA4 in
HDLvery low density lipoprotein interactions should be
considered.
Key Words: amyloidosis atherosclerosis inflammation apolipoproteins adenoviruses
This article has been cited by other articles:
![]() |
S. P. Tam, J. B. Ancsin, R. Tan, and R. Kisilevsky Peptides derived from serum amyloid A prevent, and reverse, aortic lipid lesions in apoE-/- mice J. Lipid Res., October 1, 2005; 46(10): 2091 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Anderson, C. Dunn, A. Laughter, L. Yoon, C. Swanson, T. M. Stulnig, K. R. Steffensen, R. A.S. Chandraratna, J.-A. Gustafsson, and J. C. Corton Overlapping Transcriptional Programs Regulated by the Nuclear Receptors Peroxisome Proliferator-Activated Receptor {alpha}, Retinoid X Receptor, and Liver X Receptor in Mouse Liver Mol. Pharmacol., December 1, 2004; 66(6): 1440 - 1452. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |